Sort
10,766 grants matching “checkpoint inhibitor”
Project 3 - Genome-Guided Therapeutic Vulnerabilities in Esophageal Cancer
$326,214Adam Joel Bass · Columbia University Health Sciences · P01 · FY2019 · CA
Targeted immunotherapy for relapsed/refractory Hodgkin lymphoma
$326,033Robert Wi Chen · Beckman Research Institute/City Of Hope · P50 · FY2019 · CA
Human Biosamples Core
$326,023Elizabeth W Karlson · Brigham And Women'S Hospital · P30 · FY2025 · AR
Mechanisms of Progression in Oncogene-Incuded Prostate Cancer
$325,941Timothy C Thompson · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
Immunotherapeutic targeting of MIF-dependent chaperone activity
$325,842Robert A. Mitchell · University Of Louisville · R01 · FY2024 · CA
Validating the protein binding domain of replication protein A as a cancer target
$325,775Stephen W. Fesik · Vanderbilt University · R01 · FY2016 · CA
Validating the protein binding domain of replication protein A as a cancer target
$325,775Stephen W. Fesik · Vanderbilt University · R01 · FY2015 · CA
14 3 3 Implications in Topoisomerase II Pharmacology
$325,736Research Triangle Institute · R01 · FY2003 · CA
14 3 3 Implications in Topoisomerase II Pharmacology
$325,697Research Triangle Institute · R01 · FY2002 · CA
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
$325,680Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Molecular Targeted Radionuclide Therapy with Tumor-Specific Vaccine to Stimulate and Expand T-cell Activation
$325,547Douglas G McNeel · University Of Wisconsin-Madison · P01 · FY2021 · CA
SPINK7 in allergic inflammation
$325,412Marc E. Rothenberg · Cincinnati Childrens Hosp Med Ctr · U19 · FY2019 · AI
B55 alpha deficiency as a therapeutic target in cancer
$325,395Junran Zhang · Ohio State University · R01 · FY2024 · CA
Function and Regulation of Pin2/TRF1 and PinX1
$325,370Beth Israel Deaconess Medical Center · R01 · FY2005 · GM
p53 and checkpoint pathways in cancer cell repliction
$325,345Anindya Dutta · University Of Virginia · R01 · FY2008 · CA
p53 and checkpoint pathways in cancer cell repliction
$325,345Anindya Dutta · University Of Virginia · R01 · FY2007 · CA
Cdk-2 Independent role of cyclin E in Cell survival
$325,302Alexandru Almasan Almasan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2009 · CA
Cdk-2 Independent role of cyclin E in Cell survival
$325,302Alexandru Almasan Almasan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · CA
Validating the protein binding domain of replication protein A as a cancer target
$325,256Stephen W. Fesik · Vanderbilt University · R01 · FY2014 · CA
Fu - Proj 3
$325,152Feng Fu · Dartmouth College · P20 · FY2021 · GM
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
$325,059Qing Yi · Methodist Hospital Research Institute · R01 · FY2019 · CA
The Pancreatic Cancer Microenvironment
$325,020Rui Kang · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
Novel chemistry to improve the biostability of organo-astatine bonds in alpha-emitting radiopharmaceutical therapeutics
$325,000Hsiaoju Sharon Lee · University Of Pennsylvania · R21 · FY2022 · EB
Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis
$324,901Suzanne A Fuqua · Baylor College Of Medicine · R01 · FY2024 · CA
Targeting EphB4-ephrinB2 to decrease immunosuppression in HNSCC
$324,855Sana D Karam · University Of Colorado Denver · P50 · FY2022 · CA